ILLUMINA, INC. ILMN

Technology SIC 3826 - Laboratory Analytical Instruments NAICS Manufacturing › Computer and Electronic Product Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing derived Nasdaq

Last close 269.42 2026-10-23
Market cap $40.68B 2026-06-28 share count
52-week range 94.00 - 309.35

Valuation FY2025 figures against the last close

P/S9.4x
P/E49.4x
P/FCF43.7x
EV/EBITDA37.8x
Dividend yield—
Diluted EPS5.45

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $4.34B$4.37B$4.50B$4.58B$4.53B$3.24B$3.54B$3.33B$2.75B$2.40B
Cost of revenue $1.47B$1.51B$1.76B$1.61B$1.37B$1.04B$1.08B$1.03B$926.0M$732.0M
Gross profit $2.87B$2.86B$2.74B$2.97B$3.15B$2.20B$2.47B$2.30B$1.83B$1.67B
R&D $967.0M$1.17B$1.35B$1.32B$1.19B$682.0M$647.0M$623.0M$546.0M$504.0M
SG&A $1.09B$1.09B$1.61B$1.30B$2.09B$941.0M$835.0M$794.0M$674.0M$584.0M
Total operating expenses $2.06B$3.69B$3.81B$7.15B$3.28B$1.62B$1.48B$1.42B$1.22B$1.08B
Operating income $807.0M-$833.0M-$1.07B-$4.18B-$123.0M$580.0M$985.0M$883.0M$606.0M$587.0M
Interest expense $101.0M$100.0M$77.0M$26.0M$61.0M$49.0M$52.0M$57.0M$37.0M$33.0M
Pre-tax income $1.09B-$1.18B-$1.12B-$4.34B$884.0M$856.0M$1.12B$894.0M$1.04B$561.0M
Income tax $236.0M$44.0M$44.0M$68.0M$122.0M$200.0M$128.0M$112.0M$365.0M$133.0M
Net income $850.0M-$1.22B-$1.16B-$4.40B$762.0M$656.0M$1.00B$826.0M$726.0M$463.0M
EPS, basic 5.47-7.69-7.34-28.005.074.486.815.634.963.09
EPS, diluted 5.45-7.69-7.34-28.005.044.456.745.564.923.07
Shares, diluted (wtd. avg.) 156.0M159.0M158.0M157.0M151.0M148.0M149.0M149.0M148.0M148.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $1.42B$1.13B$1.05B$2.01B$1.23B$1.81B$2.04B$1.14B$1.23B$735.0M
Short-term investments $215.0M$93.0M$6.0M$26.0M$107.0M$1.66B$1.37B$2.37B$920.0M$824.0M
Receivables $854.0M$735.0M$734.0M$671.0M$648.0M$487.0M$573.0M$514.0M$411.0M$381.0M
Inventory $564.0M$547.0M$587.0M$568.0M$431.0M$372.0M$359.0M$386.0M$333.0M$300.0M
Total current assets $3.29B$2.75B$2.61B$3.56B$2.71B$4.48B$4.45B$4.49B$2.98B$2.32B
Property, plant and equipment $759.0M$815.0M$1.01B$1.09B$1.02B$922.0M$889.0M$1.07B$931.0M$713.0M
Goodwill $1.11B$1.11B$2.54B$3.24B$7.11B$897.0M$897.0M$831.0M$771.0M$776.0M
Other intangibles $210.0M$295.0M$2.99B$3.29B$3.25B$142.0M$145.0M$185.0M$175.0M$243.0M
Total assets $6.64B$6.30B$10.11B$12.25B$15.22B$7.58B$7.32B$6.96B$5.26B$4.28B
Accounts payable $240.0M$221.0M$245.0M$293.0M$332.0M$192.0M$149.0M$184.0M$160.0M$138.0M
Short-term debt —————$511.0M$0$1.11B$10.0M$2.0M
Total current liabilities $1.58B$1.55B$1.57B$2.77B$1.09B$1.24B$665.0M$1.80B$746.0M$705.0M
Long-term debt —————$673.0M$1.14B$890.0M$1.18B$1.06B
Retained earnings -$392.0M-$1.24B-$19.0M$1.14B$5.49B$4.72B$4.07B$3.08B$2.26B$1.49B
Total equity $2.72B$2.37B$5.75B$6.60B$10.74B$4.69B$4.61B$3.85B$2.75B$2.27B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $1.08B$837.0M$478.0M$392.0M$545.0M$1.08B$1.05B$1.14B$875.0M$779.0M
Depreciation and amortisation $270.0M$354.0M$432.0M$394.0M$251.0M$187.0M$188.0M$179.0M$156.0M$141.0M
Stock-based compensation $275.0M$370.0M$380.0M$366.0M$754.0M$194.0M$194.0M$193.0M$164.0M$129.0M
Capital expenditure $148.0M$128.0M$195.0M$286.0M$208.0M$189.0M$209.0M$296.0M$310.0M$260.0M
Investing cash flow -$55.0M-$178.0M-$231.0M-$591.0M-$1.07B-$554.0M$745.0M-$1.81B-$214.0M-$515.0M
Financing cash flow -$744.0M-$570.0M-$1.21B$1.00B-$51.0M-$766.0M-$897.0M$594.0M-$176.0M-$296.0M
Buybacks $742.0M$116.0M$0$0$0$736.0M$324.0M$201.0M$251.0M$249.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-149669.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B -2.5B 0 2.5B 5B Revenue, FY2016: 2.4B Gross profit, FY2016: 1.7B Net income, FY2016: 463M Revenue, FY2017: 2.8B Gross profit, FY2017: 1.8B Net income, FY2017: 726M Revenue, FY2018: 3.3B Gross profit, FY2018: 2.3B Net income, FY2018: 826M Revenue, FY2019: 3.5B Gross profit, FY2019: 2.5B Net income, FY2019: 1B Revenue, FY2020: 3.2B Gross profit, FY2020: 2.2B Net income, FY2020: 656M Revenue, FY2021: 4.5B Gross profit, FY2021: 3.2B Net income, FY2021: 762M Revenue, FY2022: 4.6B Gross profit, FY2022: 3B Net income, FY2022: -4.4B Revenue, FY2023: 4.5B Gross profit, FY2023: 2.7B Net income, FY2023: -1.2B Revenue, FY2024: 4.4B Gross profit, FY2024: 2.9B Net income, FY2024: -1.2B Revenue, FY2025: 4.3B Gross profit, FY2025: 2.9B Net income, FY2025: 850M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $2.40B $2.75B $3.33B $3.54B $3.24B $4.53B $4.58B $4.50B $4.37B $4.34B
Gross profit $1.67B $1.83B $2.30B $2.47B $2.20B $3.15B $2.97B $2.74B $2.86B $2.87B
Net income $463.0M $726.0M $826.0M $1.00B $656.0M $762.0M -$4.40B -$1.16B -$1.22B $850.0M

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Other event Item 8.01
  • Other event Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Other event Item 8.01
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3826

TickerCompanyMarket capP/ERevenue growth
A AGILENT TECHNOLOGIES, INC. $48.79B 37.9x 6.7%
WAT WATERS CORP /DE/ $44.57B 42.2x 7.0%
MTD METTLER TOLEDO INTERNATIONAL INC/ $33.47B 39.7x 4.0%
RVTY REVVITY, INC. $17.72B 76.7x 3.7%
AVTR Avantor, Inc. $11.80B — -3.4%
BIO BIO-RAD LABORATORIES, INC. $9.89B 13.3x 0.7%
TXG 10x Genomics, Inc. $9.30B — 5.2%
BRKR BRUKER CORP $8.74B — 2.1%